Theravance Biopharma
TBPH
#6136
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
EPS for Theravance Biopharma (TBPH)
EPS in 2023 (TTM): $11.36
According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is $11.36. In 2022 the company made an earnings per share (EPS) of $11.54 an increase over its 2021 EPS that were of -$2.95.
EPS history for Theravance Biopharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $11.36 | -1.56% |
| 2022 | $11.54 | -491.19% |
| 2021 | -$2.95 | -34.15% |
| 2020 | -$4.48 | 5.16% |
| 2019 | -$4.26 | 6.5% |
| 2018 | -$4.00 | -26.61% |
| 2017 | -$5.45 | 28.24% |
| 2016 | -$4.25 | -20.26% |
| 2015 | -$5.33 | -28.27% |
| 2014 | -$7.43 | 53.38% |
| 2013 | -$4.84 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.88 | -92.25% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | -$0.33 | -102.90% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.10 | -90.32% | 🇺🇸 USA |
 Catalent CTLT | -$1.29 | -111.36% | 🇺🇸 USA |